Under RAPS

Find out what’s going on with your RAPS. Programs, conference information and celebrations of members’ accomplishments are detailed here.

Search:

17 May 2012

Considering Risk Evaluation and Mitigation Strategies (REMS)

By Zachary Brousseau

Every drug comes with some risk. The key issue for regulators, drugmakers, healthcare professionals and patients alike is whether the likely benefit is greater than the risk. This is the question [Read More...]

Tags:

FDA

FDAAA

MedGuide

REMS

Risk Evaluation and Mitigation Strategies

RiskMAP
Categories: Under RAPS

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

Under RAPS

Considering Risk Evaluation and Mitigation Strategies (REMS)

Get RF Today